European Medicines Agency (EMA) | News and press releases Follow First treatment for serious chronic lung disease EMA has recommended granting a marketing authorisation in the European Union (EU) for Brinsupri (brensocatib) 25 mg tablets, for the treatment of non-cystic fibrosis… https://www.ema.europa.eu/en/news/first-treatment-serious-chronic-lung-disease ema.europa.eu
